474 filings
Page 6 of 24
4
mdbm66 0sna6w84ws
27 Jun 22
ANAPTYSBIO / ERIC J LOUMEAU ownership change
7:04pm
4
hchd3
27 Jun 22
ANAPTYSBIO / Paul F. Lizzul ownership change
7:03pm
8-K
vk98aucbrd 9o8s2lj
24 Jun 22
Submission of Matters to a Vote of Security Holders
4:05pm
4
f2l9m
10 Jun 22
ANAPTYSBIO / ERIC J LOUMEAU ownership change
5:22pm
4
vt5axii5fzs4dus5
20 May 22
ANAPTYSBIO / ERIC J LOUMEAU ownership change
4:42pm
SC 13G/A
hcyhponayfhmn
10 May 22
ANAPTYSBIO / FEDERATED HERMES ownership change
12:08pm
4
s5rao9b42qqmjfx 9bb
9 May 22
ANAPTYSBIO / OLEG NODELMAN ownership change
6:04am
8-K
hszx6zr fuja
4 May 22
AnaptysBio Announces First Quarter 2022 Financial Results and Provides Pipeline Update
4:19pm
DEFA14A
qfwi2qaxk42sefz8rsi
29 Apr 22
Additional proxy soliciting materials
5:00pm
8-K
9nhldy q4
29 Apr 22
Departure of Directors or Certain Officers
4:06pm
8-K
a5rxo3s7wll1 i0
27 Apr 22
AnaptysBio Announces Positive ANB032 (anti-BTLA agonist) Top-Line Phase 1 Data and Provides Pipeline Updates
4:18pm
4
jk0kalxwszmj751gly
23 Mar 22
ANAPTYSBIO / Daniel Faga ownership change
4:48pm
8-K
edlats1hzw dh69
21 Mar 22
Departure of Directors or Certain Officers
5:15pm
8-K
1cx1q 4gpr32hx45jud
14 Mar 22
AnaptysBio Reports Imsidolimab ACORN Phase 2 Clinical Trial Data in Moderate-to-Severe Acne
4:26pm
S-8
uykhyc8 3ciu
7 Mar 22
Registration of securities for employees
9:01am
8-K
8j3xy7
7 Mar 22
AnaptysBio Announces Fourth Quarter and Full Year 2021 Financial Results and Provides Pipeline Update
8:53am
SC 13G/A
0rqmmn3r6
15 Feb 22
ANAPTYSBIO / PERCEPTIVE ADVISORS ownership change
12:00am